Daniel Apel

Daniel Apel

Director Financiero/CFO en ARROWHEAD PHARMACEUTICALS, INC. .

Fortuna: 14 M $ al 30/06/2026

Health Technology
Consumer Services
Commercial Services

Perfil

Daniel J.
Apel
is currently Director at Conceptus, Inc. since 2013, Director at Biotechnology Innovation Organization, and Chief Financial Officer at Arrowhead Pharmaceuticals, Inc. starting in 2025.
Formerly, Mr. Apel was Chief Financial Officer at Bayer Corp.
from 2016 to 2019 and Global Head-Financial Planning & Analysis at Walgreens Boots Alliance, Inc. from 2019 to 2024.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from the University of California, Berkeley.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
06/01/2026 176.200 ( 0,13 % ) 14 M $ 30/06/2026

Cargos activos de Daniel Apel

EmpresasCargoInicio
ARROWHEAD PHARMACEUTICALS, INC. Director Financiero/CFO 13/05/2025
Director/Miembro de la Junta -
Director/Miembro de la Junta 05/06/2013

Antiguos cargos conocidos de Daniel Apel.

EmpresasCargoFin
WALGREENS BOOTS ALLIANCE, INC. Corporate Officer/Principal 01/01/2024
Director Financiero/CFO 01/01/2019
Ver el detalle de la experiencia de Daniel Apel.

Formación de Daniel Apel.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

68

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Retail Trade